Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BGB-5777 |
Synonyms | |
Therapy Description |
BGB-5777 inhibits indoleamine 2,3-dioxygenase 1 (IDO1). which results in decreased breakdown of tryptophan to kyenurinine and potentially leads to enhanced anti-tumor immune response (PMID: 29500275). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BGB-5777 | BGB5777|BGB 5777 | IDO1 Inhibitor 12 | BGB-5777 inhibits indoleamine 2,3-dioxygenase 1 (IDO1). which results in decreased breakdown of tryptophan to kyenurinine and potentially leads to enhanced anti-tumor immune response (PMID: 29500275). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|